EQR vs PRAX · P/E 26, $26.37B cap vs $7.38B cap
Equity Residential (EQR) versus Praxis Precision Medicines Inc (PRAX) — a side-by-side from cached financials, not a winner call.
Equity Residential (EQR) is a reit - residential company listed on US.
Praxis Precision Medicines Inc (PRAX) is a biotechnology company listed on US.
EQR does not have a complete income-statement cache yet.
Latest reported PRAX revenue for 2025-09-30 was $0. Net income was -$73.9M. PRAX currently screens at market cap $7.38B.
EQR currently screens at market cap $26.37B and trailing P/E 25.7. PRAX currently screens at market cap $7.38B.
Not investment advice. Open the EQR and PRAX stock pages for the full models.
Not investment advice.